Jason DeVoss

4PUBLICATIONS
76CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 03, 2026
Coordinated Immune Activation Following KRAS Inhibition in Syngeneic Models Reveals Molecular Pathways that Potentiate and Limit Antitumor Immunity.

|Sep 16, 2024
AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers.

Brian Belmontes, Katherine K Slemmons, Chun Su

|Aug 26, 2021
Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors.

Brian Belmontes, Deepali V Sawant, Wendy Zhong

|Apr 22, 2018
Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.

Teresita L Arenzana, Steve Lianoglou, Akiko Seki

Pageof 1

Frequent Collaborators

2 joint publications

Rajkumar Noubade

2 joint publications

Angela Coxon

2 joint publications

Famke Aeffner

2 joint publications

Hong Tan